Department of Pharmacy, Xuanwu Hospital, Capital Medical University, Suying Yan, No.45 Changchun Street, Xicheng District, Beijing, China.
Department of Biostatistics, Peking University Clinical Research Institution, Beijing, China.
Int J Clin Pharm. 2022 Jun;44(3):619-629. doi: 10.1007/s11096-022-01380-0. Epub 2022 Feb 25.
Background Geriatric outpatients with polypharmacy have a high risk of potentially inappropriate medication (PIM) use. Aim To identify differences in both prevalence and patterns of PIMs and drug-related problems (DRPs) in older outpatients who visited the tertiary hospitals (THs) and community health centers (CHCs) and analyze associated factors. Method A prospective cross-sectional study was conducted in five THs and five CHCs from September 2018 to November 2019 in Beijing, China. Data were collected from outpatients aged ≥ 65 years with chronic diseases and polypharmacy. PIMs were evaluated using the 2015 and 2019 Beers Criteria and the Screening Tool of Older Persons' Prescriptions (STOPP) criteria. DRPs were classified using the Helper-Strand DRP Classification. The prevalence and types of PIMs and DRPs were compared, and relevant factors were analyzed. Results The prevalence of PIMs based on the 2015 Beers Criteria was higher in patients from the THs, while PIMs based on the 2019 Beers Criteria did not show a significant difference. PIM prevalence based on STOPP Criteria and DRPs was higher in patients from CHCs. Visiting CHCs was an independent factor of PIMs based on the 2015 Beers Criteria (OR 0.774, 95% CI 0.604-0.992) and the STOPP Criteria (OR 2.427, 95% CI 1.883-3.128), and DRPs (OR 3.612, 95% CI 2.682-4.865). Conclusion Differences in PIM and DRP might be due to the patients and settings. Specific measures to improve the appropriateness of medications in both settings should be used.
患有多种药物治疗的老年门诊患者有潜在不适当用药(PIM)的高风险。目的:确定在三级医院(THs)和社区卫生中心(CHCs)就诊的老年门诊患者中 PIM 和药物相关问题(DRP)的流行率和模式的差异,并分析相关因素。方法:本研究为 2018 年 9 月至 2019 年 11 月在中国北京的五家 THs 和五家 CHCs 进行的前瞻性横断面研究。数据收集自患有慢性病和多种药物治疗的 65 岁及以上的门诊患者。使用 2015 年和 2019 年的 Beers 标准以及老年人处方筛选工具(STOPP)标准评估 PIM。使用 Helper-Strand DRP 分类法对 DRP 进行分类。比较了 PIM 和 DRP 的流行率和类型,并分析了相关因素。结果:基于 2015 年 Beers 标准的 PIM 患病率在 THs 患者中较高,而基于 2019 年 Beers 标准的 PIM 患病率则无显著差异。基于 STOPP 标准的 PIM 患病率和 DRP 在 CHCs 患者中较高。就诊于 CHCs 是基于 2015 年 Beers 标准(OR 0.774,95%CI 0.604-0.992)和 STOPP 标准(OR 2.427,95%CI 1.883-3.128)的 PIM 以及 DRP(OR 3.612,95%CI 2.682-4.865)的独立因素。结论:PIM 和 DRP 的差异可能是由于患者和环境造成的。应针对两种环境采取具体措施来提高药物治疗的适当性。